About the survey - First phase of an ongoing, multicentre observational study - First five countries include: UK, Sweden, Denmark, Germany, Ireland - 11 palliative care units - 400 patients with breakthrough cancer pain - Data collected on breakthrough cancer pain and treatment of breakthrough cancer pain - First results are based on 200 patients from UK (80), Sweden (80) and Denmark (40) - The study is supported by an educational grant from Nycomed.
For further information:
Media: Ulf Jonson, Senior International Brand Manager, Nycomed: +45-46-77-10-78
First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain
LISBON, Portugal, September 9 /PRNewswire/ --
- Choosing a More Appropriate Route of Administration for Fast Acting Pain Relief Could be the key to Improvement
The first results of the first European survey of cancer patients' experience of breakthrough pain were presented today at the 6th congress of the European Federation of Chapters of the International Association for the Study of Pain (EFIC).
Previous surveys have looked at the overall management of pain in cancer
patients but this is the first international study to look in detail at
Breakthrough Cancer Pain (BTCP) from a patient perspective. These results for
the first 200 patients from the UK, Sweden and Denmark offer valuable insight
into cancer patients' experiences with breakthrough pain management and the
Copyright©2009 PR Newswire.
All rights reserved